TickerFacts.

TherapeuticsMD, Inc. (TXMD): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

11.57M
Year ended 2025-12-31
+7.3%
3-year compound annual growth
2021-12-31: 7.96M2022-12-31: 9.37M2023-12-31: 10.44M2024-12-31: 11.53M2025-12-31: 11.57M11.57M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3111.57M+0.3%2026-04-01, From 2025-01-01
2024-12-3111.53M+10.4%2026-04-01, From 2024-01-01
2023-12-3110.44M+11.5%2024-03-29, From 2023-01-01
2022-12-319.37M+17.7%2024-03-29, From 2022-01-01
2021-12-317.96Mn/a2023-04-07, From 2021-01-01